CARESTAR study may ‘open the floodgates’ to more appropriate, personalised treatment of symptomatic non-stenotic carotid disease

NOTE: This video is ONLY available to watch in selected countries and geographies


RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here